Higher heart risk seen with increased troponin rates in diabetes

02/18/2013 | Medscape (free registration)

More than a fifth of stable diabetes patients examined showed slight elevations in cardiac troponin I levels and had a 50% increased risk of major adverse cardiac events over three years, researchers found. The results, published in Diabetes Care, "imply that any detectable cTnI level should warrant consideration for more globally aggressive risk-reduction efforts, including closer evaluation and long-term monitoring, and such intervention efforts may focus beyond glycemic-control measures," said researcher Dr. W.H. Wilson Tang.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA